Simulations Plus: AI Simulation Instead of Animal Testing! FDA Promotes Innovative Techniques in Drug Research! Stock Surge!

The "Healthcare" sector is currently in the middle range among all sectors. Last week, a groundbreaking announcement by the FDA caused significant momentum in the price movements of some stocks from the "Health Information Services" industry. We are taking a closer look at the leader Simulations Plus, which has recorded an increase of over 30% in just one month. Why? Simulations Plus is a provider of software for the pharmaceutical industry AI models and simulation programs aim to reduce development costs FDA promotes AI-based simulations...